Effect of tirzepatide on glycaemic control and weight loss compared with other glucagon-like peptide-1 receptor agonists in Japanese patients with type 2 diabetes mellitus.

Shunichiro TsukamotoShohei TanakaTakayuki YamadaKazushi UnedaKengo AzushimaSho KinguchiHiromichi WakuiKouichi Tamura

Published in: Diabetes, obesity & metabolism (2023)

Among Japanese patients with T2D, tirzepatide showed the greatest effectiveness in reducing HbA1c levels and inducing weight loss. The study provides evidence to guide GLP-1RA treatment strategies in Japanese patients with T2D.

Keyphrases

weight loss
bariatric surgery
roux en y gastric bypass
gastric bypass
type diabetes
randomized controlled trial
rheumatoid arthritis
systematic review
obese patients
weight gain
metabolic syndrome
skeletal muscle
ankylosing spondylitis